Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults

BACKGROUND: Rilpivirine (RPV), a recently developed, once daily HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), is not currently approved for pediatric patients, but is sometimes prescribed for adolescents with multiple treatment failures, for regimen simplification or to minimize toxici...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatr Infect Dis J
Hlavní autoři: Foca, Marc, Yogev, Ram, Wiznia, Andrew, Hazra, Rohan, Jean-Philippe, Patrick, Graham, Bobbie, Britto, Paula, Carey, Vincent J., King, Jennifer, Acosta, Edward P., Cressey, Tim R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5245132/
https://ncbi.nlm.nih.gov/pubmed/27187753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001214
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky